|20.69||-0.27 / -1.29%|
Data as of 4:07pm ET
|20.69||0.00 / 0.00%|
The 10 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 29.00, with a high estimate of 34.00 and a low estimate of 24.00. The median estimate represents a +40.16% increase from the last price of 20.69.
The current consensus among 10 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.